Pharmacokinetic and pharmacodynamic properties of metronidazole in pediatric patients with acute appendicitis: a prospective study
Journal of the Pediatric Infectious Diseases Society Jun 01, 2018
Child J, et al. - Pediatric patients with appendicitis given metronidazole once daily were studied to determine if this dosing would meet target area under the curve (AUC)/minimum inhibitory concentration (MIC) ratio of ≥70 for Bacteroides fragilis. After a 30 mg/kg per dose of intravenous metronidazole, 100 pediatric patients aged 4–17 years had an average of 3 blood draws per patient during the first 24 hours. Findings revealed that in these patients, metronidazole, 30 mg/kg per dose, once daily achieved AUC target attainment for B fragilis with an MIC of 2 mcg/mL or less. This study and the studies in adults did not suggest any pharmacokinetics-pharmacodynamics advantage of more frequent dosing in this population.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries